Genomics of drug sensitivity in bladder cancer: an integrated resource for pharmacogenomic analysis in bladder cancer

被引：0
作者：
Adnan Ahmad Ansari
Inkeun Park
Inki Kim
Sojung Park
Sung-Min Ahn
Jae-lyun Lee
机构：
[1] University of Ulsan College of Medicine,Department of Biomedical Engineering
[2] Asan Center for Cancer Genome Discovery,Division of Medical Oncology, Department of Internal Medicine
[3] Asan Institute for Life Sciences,Department of Genome Medicine and Science, College of Medicine
[4] Asan Medical Center,Departments of Oncology, Asan Medical Center
[5] Gachon University Gil Hospital,Department of Internal Medicine
[6] Gachon University,undefined
[7] Asan Institute for Life Sciences,undefined
[8] Asan Medical Center,undefined
[9] Gachon University,undefined
[10] University of Ulsan College of Medicine,undefined
[11] Asan Medical Center,undefined
[12] University of Ulsan College of Medicine,undefined
来源：
BMC Medical Genomics | / 11卷
关键词：
Bladder cancer; Database; Drug response; Pharmacogenomics; Therapeutic biomarker;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 119 条
[21]  
Vaughn DJ(2014)PD173074, a selective FGFR inhibitor, reverses MRP7 (ABCC10)-mediated MDR Acta Pharm Sin B 4 202-207
[22]  
Fradet Y(2006)Epidermal growth factor receptor (EGFR) signaling in cancer Gene 366 2-16
[23]  
Lee J-L(2013)Targeting the ERBB family in cancer: couples therapy Nat Rev Cancer 13 663-673
[24]  
Fong L(2015)The genomics of drug sensitivity in Cancer consortium. Pharmacogenomic agreement between two cancer cell line data sets Nature 528 84-87
[25]  
Jandaghi P(undefined)undefined undefined undefined undefined-undefined
[26]  
Hoheisel JD(undefined)undefined undefined undefined undefined-undefined
[27]  
Riazalhosseini Y(undefined)undefined undefined undefined undefined-undefined
[28]  
Zardavas D(undefined)undefined undefined undefined undefined-undefined
[29]  
Baselga J(undefined)undefined undefined undefined undefined-undefined
[30]  
Piccart M(undefined)undefined undefined undefined undefined-undefined
12345678910